Back to search
Familial Hypobetalipoproteinemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hypobetalipoproteinemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hypobetalipoproteinemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of this study is to identify new targets in cholesterol metabolism thanks to a genetically-based strategy.
To evaluate the kinetics of intestinal absorption of vitamin E water-soluble form from the classical lipid-soluble form in a population of patients with intesti…
Rationale. ANGPTL3 has been identified as important regulator of lipolysis as well as a determinant of plasma levels of apolipoprotein B-containing lipoproteins…
The links between low LDL-C levels and psychologic symptoms (psychotic disorders, mood disorders, aggressivity, suicidal risk, etc.) and cognitive deficits (mai…
The pilot study has the target to evaluate the outcomes of two novel mutations in the gene of Apolipoprotein B (ApoB). ApoB is the main part of the low-density…
Familial hypobetalipoproteinemia (FHBL, OMIM # 1707730) is a genetic disorder heterozygotic of LDL-C metabolism. Clinical manifestation range from asymptomatic…
To determine mechanisms of low levels of apolipoprotein B.